Tamsulosin hydrochloride and Klor-con m20 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tamsulosin hydrochloride and Klor-con m20. Common interactions include atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people who take Tamsulosin hydrochloride and Klor-con m20 have. It is created by eHealthMe based on reports of 13 people who take Tamsulosin hydrochloride and Klor-con m20 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

13 people who take Tamsulosin hydrochloride and Klor-con m20 together, and have interactions are studied.

What is Tamsulosin hydrochloride?

Tamsulosin hydrochloride has active ingredients of tamsulosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 12,701 Tamsulosin hydrochloride users for its effectiveness, alternative drugs and more.

What is Klor-con m20?

Klor-con m20 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,997 Klor-con m20 users for its effectiveness, alternative drugs and more.

Number of Tamsulosin hydrochloride and Klor-con m20 reports submitted per year:

Common Tamsulosin Hydrochloride and Klor-Con M20 drug interactions by gender *:

female:

n/a

male:

Atrial fibrillation
Heart rate increased
Vision blurred
Abdominal pain upper
Acute respiratory failure
Arterial rupture
Arthralgia
Arthritis
Aspartate aminotransferase increased
Asthenia

Common Tamsulosin Hydrochloride and Klor-Con M20 drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Acute respiratory failure
Aspartate aminotransferase increased
Cancer pain
Disease progression
Hypercapnia
Hypoxia
Iron deficiency anaemia
Leukopenia
Mental status changes
Metabolic encephalopathy

50-59:

n/a

60+:

Atrial fibrillation
Heart rate increased
Arthralgia
Arthritis
Asthenia
Bubonic plague
Cardiac failure congestive
Cataplexy
Cataract
Cellulitis

Common conditions people have *:

Multiple Myeloma (cancer of the plasma cells): 4 people, 30.77%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 23.08%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 23.08%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 7.69%
High Blood Cholesterol: 1 person, 7.69%
Amyloidosis (a tumour within which amyloid is produced): 1 person, 7.69%
Blood Potassium Abnormal: 1 person, 7.69%
Cardiac Amyloidosis (protein deposition in heart): 1 person, 7.69%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.69%
Gout (uric acid crystals building up in the body): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tamsulosin hydrochloride and Klor-con m20?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.